CAPROCK Group, Inc.

SEC CIK: 0001610769
Latest filing: Jul 27, 2026

SEC filings (opens in a new tab)

ADPT holding history

Adaptive Biotechnologies Corp in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADPT overview All 13F holders of ADPT Full Q2 2026 holdings

Shares (Q2 2026): 10,497
Value: $225.2K
% of portfolio: <0.1%
Quarters held: 21; Since Q1 2021

Holdings of ADPT by CAPROCK Group, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	10,497	$225.2K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	10,497	$145.7K	<0.1%	+158+1.5%	Added	Holders
Q4 2025	10,339	$167.9K	<0.1%	−568−5.2%	Reduced	Holders
Q3 2025	10,907	$143.8K	<0.1%	–	No prior filing	Holders
Q2 2025	–	–	–	–	Not filed	Holders
Q1 2025	10,944	$81.3K	<0.1%	+529+5.1%	Added	Holders
Q4 2024	10,415	$62.4K	<0.1%	−2,500−19.4%	Reduced	Holders
Q3 2024	12,915	$66.1K	<0.1%	+357+2.8%	Added	Holders
Q2 2024	12,558	$45.5K	<0.1%	−12,516−49.9%	Reduced	Holders
Q1 2024	25,074	$80.5K	<0.1%	−28−0.1%	Reduced	Holders
Q4 2023	25,102	$123.0K	<0.1%	−17−0.1%	Reduced	Holders
Q3 2023	25,119	$136.9K	<0.1%	−300−1.2%	Reduced	Holders
Q2 2023	25,419	$170.6K	<0.1%	00.0%	Unchanged	Holders
Q1 2023	25,419	$224.4K	<0.1%	00.0%	Unchanged	Holders
Q4 2022	25,419	$194.2K	<0.1%	−1,919−7.0%	Reduced	Holders
Q3 2022	27,338	$195.0K	<0.1%	−414−1.5%	Reduced	Holders
Q2 2022	27,752	$225.0K	<0.1%	−4,586−14.2%	Reduced	Holders
Q1 2022	32,338	$449.0K	<0.1%	−3,000−8.5%	Reduced	Holders
Q4 2021	35,338	$992.0K	0.1%	−10,700−23.2%	Reduced	Holders
Q3 2021	46,038	$1.56M	0.1%	00.0%	Unchanged	Holders
Q2 2021	46,038	$1.88M	0.2%	−3,000−6.1%	Reduced	Holders
Q1 2021	49,038	$1.97M	0.2%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.